Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Aya Gold & Silver Inc. released its 2025 Sustainability Report showcasing meaningful advancements in environmental management—such as reduced water and greenhouse gas intensities—robust social investments in local communities and employee training, and enhanced governance practices including ESG-linked executive incentives and increased female work…
Celularity Inc. and Fountain Life announce the availability of cenplacel-L, a placental-derived allogeneic cell therapy, for investigational use by licensed physicians in Florida under recently enacted state legislation. This new regulatory framework allows use of certain cell therapies without FDA approval, enabling physician-directed application …
ARS Pharmaceuticals has announced a collaboration with former NFL star Drew Brees to raise awareness about severe food allergies and the importance of preparedness using neffy®, an FDA-approved needle-free epinephrine nasal spray. This partnership aims to educate patients and caregivers on prompt treatment of severe allergic reactions to prevent an…
ChronoScale Corporation announced the appointments of Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to accelerate the company's AI infrastructure platform growth and global compute solutions delivery. These leadership additions aim to strengthen innovation and scale operations to meet rising enterprise demand…
NextCure, Inc. announced the availability of a replay for its virtual Key Opinion Leader event discussing the first clinical efficacy data from the Phase 1 dose escalation study of SIM0505, an investigational antibody-drug conjugate targeting Cadherin-6, for ovarian and uterine serous carcinoma cancers. The event featured experts from leading cance…
Amneal Pharmaceuticals announced FDA approval of its romidepsin injection solution, a ready-to-use formulation that simplifies hospital and pharmacy preparation compared to the previously marketed lyophilized powder. The product’s Competitive Generic Therapy designation grants Amneal 180 days of market exclusivity, enhancing its differentiated inje…
VCI Global Limited (NASDAQ: VCIG) provided a strategic business update highlighting its expanding institutional investor base, which includes prominent players in digital assets and blockchain technology. The company is actively pursuing growth opportunities across artificial intelligence infrastructure, digital assets, real-world assets, and capit…
LanzaTech Global, Inc. announced the IPO of its joint venture, Beijing Shougang LanzaTech Technology Co., Ltd., on the Hong Kong Stock Exchange. The JV raised approximately $75 million, achieving a market capitalization of around $750 million. LanzaTech retained an 8.38% stake post-IPO. The listing demonstrates commercial viability of LanzaTech's c…
IMUNON, Inc. announced a structured financing deal raising up to $10 million to fund enrollment in its pivotal Phase 3 OVATION 3 trial of IMNN-001, a DNA-mediated immunotherapy for advanced ovarian cancer. The financing combines preferred stock issuance and secured promissory notes with favorable terms intended to minimize dilution. Recent Phase 2 …
Diginex Limited announced an expansion of its supply chain product suite with Risk-to-Remedy, an integrated solution for supply chain transparency and labor rights compliance, designed to help businesses comply with tightening global human rights regulations. The enhancement combines technology for risk assessment, worker engagement, and grievance …
Arvinas, Inc. announced its participation in the Michael J. Fox Foundation-supported LRRK2 Investigative Therapeutics Exchange (LITE) and Parkinson’s Precision Medicine Initiative (PPMI) programs. This collaboration aims to advance ARV-102, an investigational PROTAC drug targeting LRRK2 for treating Parkinson’s disease and related neurodegenerative…
Immutep Limited announced positive interim Phase I clinical trial results for IMP761, a first-in-class LAG-3 agonist antibody targeting autoimmune diseases. The single ascending dose study demonstrated favorable safety, tolerability, and significant pharmacodynamic activity at 7 mg/kg in healthy volunteers. These findings support further clinical d…
Provident Bank announced the promotion of Annamaria Vitelli to Executive Vice President, Chief Wealth Officer of Provident Bank, and President of its wealth management subsidiary, Beacon Trust. Vitelli will lead strategic growth initiatives across Provident's wealth management business, collaborating with business divisions to enhance integrated fi…
BIO-key International's Chairman and CEO will present at the RedChip Future Tech Investor Conference, highlighting the company's significant revenue growth and anticipated profitability in the first half of 2026. The company, a leader in biometric authentication and identity access management, expects 1H 2026 revenues to increase by 50% compared to…
Innio, the Munich-based maker of gas engines and distributed power systems, raised $2.43 billion in an upsized initial public offering and is due to begin trading in the U.S. later on Thursday. Backing from investors attracted to companies supplying the physical infrastructure for AI - particularly data-center power equipment - helped drive demand.…
HSBC is maintaining an aggressive allocation to risk assets but has been answering repeated client questions on what might trigger a shift to a bearish stance. Chief Multi-Asset Strategist Max Kettner says common concerns such as near-term U.S. earnings, geopolitics and front-end interest-rate moves rank low, while two higher-priority risks - broad…
A poll of foreign exchange analysts conducted May 29 to June 3 shows the Canadian dollar is expected to strengthen modestly against the U.S. dollar over the next year if Canada's economy stabilizes and there is headway in the review of the continental trade pact. Short-term gains hinge on resolution of trade uncertainties and an improvement in dome…
RBC Capital Markets has started coverage of Sylvania Platinum Ltd with an "outperform" rating and a 175 pence price target, implying roughly 106% upside from the current share price of 92 pence. The broker points to a robust free cash flow profile, a sum-of-the-parts adjusted NAV of $563 million (167p per share), and a key Thaba joint venture as pr…
Meredith S. Weil, Chief Financial Officer and Director at TFS Financial CORP (NASDAQ:TFSL), engaged in significant transactions involving the company's common stock on June 2, 2026. These filings detail both sales of existing shares and substantial acquisitions via option exercises. The movements occurred against a backdrop of current market valuat…
David Stevens Hooker, a director at Northpointe Bancshares Inc. (NPB), executed multiple sales of the company's common stock in early June 2026. These insider transactions occurred against a backdrop of recent financial reporting for NPB, which noted strong profitability and improved asset quality despite a decline in net interest income. The analy…
Morgan Stanley expects U.S. natural gas prices to continue recovering through the third quarter, supported by rising LNG export flows and increased power demand, but warns of potential oversupply pressures in 2027 as associated gas from the Permian and new pipeline capacity come online. The bank adjusted its 2026 price outlook modestly lower while …
Overseas buyers have tilted toward Indian government paper maturing in under five years, seizing relative value as markets increasingly price a tightening cycle. Shorter-end yields spiked on inflation worries tied to the Iran war and energy, prompting a rotation that left long-end yields more exposed to future repricing.
An Istanbul court has handed Fenerbahce chairman Sadettin Saran a prison term of two years and six months after finding him guilty of encouraging illegal betting, a decision announced shortly before the club's scheduled congress to elect a new leader. The court also convicted his brother, Kenan Saran, on the same charge. Sadettin Saran has denied w…
Alkami (ALKT) looks primed for a re-rating after a large institutional purchase, strong recent revenue growth and talk of a shareholder vote around a buyback. The balance of improving fundamentals and continued execution risk makes this a medium-risk, long-term trade: entry $16.70, stop $14.10, target $24.00 over roughly 180 trading days.
Nasdaq futures fell sharply in early trading after Broadcom reported second-quarter revenue that surged on AI chip demand but issued guidance that failed to meet some investors' expectations. S&P 500 and Dow futures held near the flatline as market participants weighed geopolitical tensions in the Middle East. Several cryptocurrency- and blockchain…
